| Rochelle Jacinto, MD | |
|
9615 Frankford Avenue, 2nd Floor, Lubbock, TX 79424 | |
| (806) 761-0267 | |
| (806) 761-0268 |
| Full Name | Rochelle Jacinto |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 9615 Frankford Avenue, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538452396 | NPI | - | NPPES |
| 339848901 | Medicaid | TX | |
| 8EP022 | Other | TX | BCBS |
| 13301560 | Medicaid | NM | |
| 282122101 | Other | TX | FIRSTCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | Q0653 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Lubbock, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umc Physicians | 9830003631 | 114 |
News Archive
A new study appears to have found another use for the drug Viagra other than for treating problems such as erectile dysfunction.
In a Huffington Post "Global Motherhood" opinion piece, UNFPA Executive Director Babatunde Osotimehin writes, "It warms my heart to see that safe motherhood and women's reproductive health are finally being recognized as important development issues," but "millions of women in developing countries still lack even the most basic care during pregnancy," leading to maternal death and injury and hundreds of millions of women lack access to family planning services, including modern contraceptives.
According to the United States Centers for Disease Control and Prevention, breast cancer is the most common cancer in women. For patients whose breast cancers are hormone-dependent, current treatment focuses on using drugs that block estrogen (a type of hormone) from attaching to estrogen receptors on tumor cells to prevent the cells from growing and spreading.
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 4 days ago
| Entity Name | Umc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669418547 PECOS PAC ID: 9830003631 Enrollment ID: O20040406001716 |
News Archive
A new study appears to have found another use for the drug Viagra other than for treating problems such as erectile dysfunction.
In a Huffington Post "Global Motherhood" opinion piece, UNFPA Executive Director Babatunde Osotimehin writes, "It warms my heart to see that safe motherhood and women's reproductive health are finally being recognized as important development issues," but "millions of women in developing countries still lack even the most basic care during pregnancy," leading to maternal death and injury and hundreds of millions of women lack access to family planning services, including modern contraceptives.
According to the United States Centers for Disease Control and Prevention, breast cancer is the most common cancer in women. For patients whose breast cancers are hormone-dependent, current treatment focuses on using drugs that block estrogen (a type of hormone) from attaching to estrogen receptors on tumor cells to prevent the cells from growing and spreading.
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 4 days ago
| Entity Name | Methodist Hospital Levelland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043328222 PECOS PAC ID: 8527041037 Enrollment ID: O20040607001572 |
News Archive
A new study appears to have found another use for the drug Viagra other than for treating problems such as erectile dysfunction.
In a Huffington Post "Global Motherhood" opinion piece, UNFPA Executive Director Babatunde Osotimehin writes, "It warms my heart to see that safe motherhood and women's reproductive health are finally being recognized as important development issues," but "millions of women in developing countries still lack even the most basic care during pregnancy," leading to maternal death and injury and hundreds of millions of women lack access to family planning services, including modern contraceptives.
According to the United States Centers for Disease Control and Prevention, breast cancer is the most common cancer in women. For patients whose breast cancers are hormone-dependent, current treatment focuses on using drugs that block estrogen (a type of hormone) from attaching to estrogen receptors on tumor cells to prevent the cells from growing and spreading.
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 4 days ago
| Entity Name | Covenant Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598904 PECOS PAC ID: 6901889393 Enrollment ID: O20040608000563 |
News Archive
A new study appears to have found another use for the drug Viagra other than for treating problems such as erectile dysfunction.
In a Huffington Post "Global Motherhood" opinion piece, UNFPA Executive Director Babatunde Osotimehin writes, "It warms my heart to see that safe motherhood and women's reproductive health are finally being recognized as important development issues," but "millions of women in developing countries still lack even the most basic care during pregnancy," leading to maternal death and injury and hundreds of millions of women lack access to family planning services, including modern contraceptives.
According to the United States Centers for Disease Control and Prevention, breast cancer is the most common cancer in women. For patients whose breast cancers are hormone-dependent, current treatment focuses on using drugs that block estrogen (a type of hormone) from attaching to estrogen receptors on tumor cells to prevent the cells from growing and spreading.
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rochelle Jacinto, MD 5219 City Bank Pkwy Ste 35, Lubbock, TX 79407-3545 Ph: (806) 761-0334 | Rochelle Jacinto, MD 9615 Frankford Avenue, 2nd Floor, Lubbock, TX 79424 Ph: (806) 761-0267 |
News Archive
A new study appears to have found another use for the drug Viagra other than for treating problems such as erectile dysfunction.
In a Huffington Post "Global Motherhood" opinion piece, UNFPA Executive Director Babatunde Osotimehin writes, "It warms my heart to see that safe motherhood and women's reproductive health are finally being recognized as important development issues," but "millions of women in developing countries still lack even the most basic care during pregnancy," leading to maternal death and injury and hundreds of millions of women lack access to family planning services, including modern contraceptives.
According to the United States Centers for Disease Control and Prevention, breast cancer is the most common cancer in women. For patients whose breast cancers are hormone-dependent, current treatment focuses on using drugs that block estrogen (a type of hormone) from attaching to estrogen receptors on tumor cells to prevent the cells from growing and spreading.
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 4 days ago
Charles Hudson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Concord Medical Group, 1602 Avenue Q, Lubbock, TX 79401 Phone: 972-829-6613 Fax: 800-611-5029 | |
Dr. Ronald L. Cook, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St, Suite 1c143, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-2563 | |
Dr. Scott W. Dahlbeck, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 602 Indiana Ave, Lubbock, TX 79415 Phone: 806-775-8600 Fax: 806-775-8608 | |
Naticia Mortensen, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5915 82nd St, Lubbock, TX 79424 Phone: 806-794-3000 Fax: 806-698-0847 | |
Ryan Daniel Lurtsema, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th Street Mail Stop 9901, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-1180 | |
Dr. Cherrylene A Lindgren, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4105 I-27, Lubbock, TX 79404 Phone: 806-762-2633 Fax: 806-761-0431 | |
Jared Zachary Brinker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 |